Breaking News

Endo Appoints R&D Head

By Kristin Brooks | March 7, 2014

Hall brings 30 years of R&D experience

Susan Hall, Ph.D. has been appointed executive vice president, chief scientific officer and global head of R&D and quality, at Endo International plc. Dr. Hall will be based in Dublin, Ireland at the company's new global corporate headquarters.
 
Prior to joining the company, Dr. Hall served as senior vice president and global head of R&D at Valeant Pharmaceuticals International, where she led the company's product pipeline and life cycle management activities with responsibility for quality compliance. Dr. Hall has also held various leadership roles in R&D at GlaxoSmithKline including clinical pharmacology, project management, medical affairs, and regulatory affairs.
 
"We are thrilled that Sue has joined the Endo team as the progression of Endo to a leading specialty healthcare company continues," said Rajiv De Silva, president and chief executive officer of Endo. "Sue brings more than 30 years of extensive multi-disciplinary and international expertise in drug development and life cycle management across a broad range of therapeutic areas along with extensive experience in quality. R&D will continue to be a key part of Endo's future organic growth plans and Sue's experience and background make her an excellent fit for the role."

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Filings Update

    Filings Update

    December 1, 2015
    Roche, Pfizer, Janssen, BMS and more

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016